Results 171 to 180 of about 3,306,946 (213)

SMALL ANIMAL PROTON ARC THERAPY PHANTOM: DESIGN AND VALIDATION

International Journal of Particle Therapy
Jiankun Qin, An Qin, Xuanfeng Ding
openaire   +1 more source

Upright, gantry-less treatments for particle therapy: a potential paradigm shift. [PDF]

Br J Radiol
Underwood TSA, Volz L, Gayar H.
europepmc   +1 more source

Mid-range arc therapy for efficient and RBE-robust proton treatment. [PDF]

Phys Med Biol
Wang Q, Chen M, Zhu Y, Zhao X, Zhang Y, Gu X, Lu W.   +6 more
europepmc   +1 more source

STAR in a Second: Ultra-High-Dose-Rate Spread-Out Bragg Peak Proton Therapy for Breath-Hold Stereotactic Arrhythmia Radioablation. [PDF]

Adv Radiat Oncol
Ramesh P, Schwarz M, Colbert C, Chen XC, Panjwani N, Bowen SR, Grassberger C, Wei C, Batnyam U, Nazer B, Nyflot MJ.   +10 more
europepmc   +1 more source

Validation of automated script-based proton therapy optimisation for comparative head and neck planning. [PDF]

Phys Imaging Radiat Oncol
Høiskar MK, Elstrøm UV, Skyt PS, Redalen KR, Almberg SS.   +4 more
europepmc   +1 more source

A model-based selection of oral cancer patient for passive scattering proton beam therapy. [PDF]

J Radiat Res
Narita Y, Takayama K, Kato T, Komori S, Seto I, Nakasato T, Murakami M.   +6 more
europepmc   +1 more source

Proton Arc Therapy Increases the Benefit of Proton Therapy for Oropharyngeal Cancer Patients in the Model Based Clinic [PDF]

Radiotherapy and Oncology, 2023
In the model-based approach, patients qualify for proton therapy when the reduction in risk of toxicity (ΔNTCP) obtained with IMPT relative to VMAT is larger than predefined thresholds as defined by the Dutch National Indication Protocol (NIPP). Proton arc therapy (PAT) is an emerging technology which has the potential to further decrease NTCPs ...
Erik Korevaar, Guillaume Janssens, Bas A de Jong   +2 more
exaly   +5 more sources